Aviram M, Rosenblat M, Billecke S, Erogul J, Sorenson R, Bisgaier C L, Newton R S, La Du B
The Lipid Research Laboratory, Technion Faculty of Medicine, the Rappaport Family Institute for Research in the Medical Sciences and Rambam Medical Center, Haifa, Israel.
Free Radic Biol Med. 1999 Apr;26(7-8):892-904. doi: 10.1016/s0891-5849(98)00272-x.
Human serum paraoxonase (PON1) can protect low density lipoprotein (LDL) from oxidation induced by either copper ion or by the free radical generator azo bis amidinopropane hydrochloride (AAPH). During LDL oxidation in both of these systems, a time-dependent inactivation of PON arylesterase activity was observed. Oxidized LDL (Ox-LDL) produced by lipoprotein incubation with either copper ion or with AAPH, indeed inactivated PON arylesterase activity by up to 47% or 58%, respectively. Three possible mechanisms for PON inactivation during LDL oxidation were considered and investigated: copper ion binding to PON, free radical attack on PON, and/or the effect of lipoprotein-associated peroxides on the enzyme. As both residual copper ion and AAPH are present in the Ox-LDL preparations and could independently inactivate the enzyme, the effect of minimally oxidized (Ox-LDL produced by LDL storage in the air) on PON activity was also examined. Oxidized LDL, as well as oxidized palmitoyl arachidonoyl phosphatidylcholine (PAPC), lysophosphatidylcholine (LPC, which is produced during LDL oxidation by phospholipase A2-like activity), and oxidized cholesteryl arachidonate (Ox-CA), were all potent inactivators of PON arylesterase activity (PON activity was inhibited by 35%-61%). PON treatment with Ox-LDL (but not with native LDL), or with oxidized lipids, inhibited its arylesterase activity and also reduced the ability of the enzyme to protect LDL against oxidation. PON Arylesterase activity however was not inhibited when PON was pretreated with the sulfhydryl blocking agent, p-hydroxymercurybenzoate (PHMB). Similarly, on using recombinant PON in which the enzyme's only free sulfhydryl group at the position of cysteine-284 was mutated, no inactivation of the enzyme arylesterase activity by Ox-LDL could be shown. These results suggest that Ox-LDL inactivation of PON involves the interaction of oxidized lipids in Ox-LDL with the PON's free sulfhydryl group. Antioxidants such as the flavonoids glabridin or quercetin, when present during LDL oxidation in the presence of PON, reduced the amount of lipoprotein-associated lipid peroxides and preserved PON activities, including its ability to hydrolyze Ox-LDL cholesteryl linoleate hydroperoxides. We conclude that PON's ability to protect LDL against oxidation is accompanied by inactivation of the enzyme. PON inactivation results from an interaction between the enzyme free sulfhydryl group and oxidized lipids such as oxidized phospholipids, oxidized cholesteryl ester or lysophosphatidylcholine, which are formed during LDL oxidation. The action of antioxidants and PON on LDL during its oxidation can be of special benefit against atherosclerosis since these agents reduce the accumulation of Ox-LDL by a dual effect: i.e. prevention of its formation, and removal of Ox-LDL associated oxidized lipids which are generated during LDL oxidation.
人血清对氧磷酶(PON1)可以保护低密度脂蛋白(LDL)免受铜离子或自由基引发剂偶氮双脒丙烷盐酸盐(AAPH)诱导的氧化。在这两种体系中LDL氧化过程中,观察到PON芳基酯酶活性随时间而失活。脂蛋白与铜离子或AAPH孵育产生的氧化LDL(Ox-LDL),确实分别使PON芳基酯酶活性失活高达47%或58%。研究了LDL氧化过程中PON失活的三种可能机制:铜离子与PON结合、自由基对PON的攻击和/或脂蛋白相关过氧化物对该酶的影响。由于Ox-LDL制剂中同时存在残余铜离子和AAPH,且它们均可独立使该酶失活,因此也检测了轻度氧化的LDL(通过将LDL暴露于空气中产生)对PON活性的影响。氧化LDL,以及氧化棕榈酰花生四烯酰磷脂酰胆碱(PAPC)、溶血磷脂酰胆碱(LPC,其在LDL氧化过程中由类似磷脂酶A2的活性产生)和氧化胆固醇花生四烯酸酯(Ox-CA),均为PON芳基酯酶活性的强效失活剂(PON活性被抑制35%-61%)。用Ox-LDL(而非天然LDL)或氧化脂质处理PON,抑制了其芳基酯酶活性,也降低了该酶保护LDL免受氧化的能力。然而,当用巯基阻断剂对羟基汞苯甲酸(PHMB)预处理PON时,其芳基酯酶活性未受抑制。同样,使用重组PON,其中该酶在半胱氨酸-284位置唯一的游离巯基发生了突变,未显示Ox-LDL能使该酶的芳基酯酶活性失活。这些结果表明,Ox-LDL使PON失活涉及Ox-LDL中的氧化脂质与PON的游离巯基相互作用。在存在PON的情况下,LDL氧化过程中存在的抗氧化剂如光甘草定或槲皮素,减少了脂蛋白相关脂质过氧化物的量,并保留了PON活性,包括其水解Ox-LDL胆固醇亚油酸氢过氧化物的能力。我们得出结论,PON保护LDL免受氧化的能力伴随着该酶的失活。PON失活是由于该酶的游离巯基与氧化脂质如氧化磷脂、氧化胆固醇酯或溶血磷脂酰胆碱之间的相互作用所致,这些氧化脂质是在LDL氧化过程中形成的。抗氧化剂和PON在LDL氧化过程中的作用对动脉粥样硬化可能具有特殊益处,因为这些物质通过双重作用减少了Ox-LDL的积累:即防止其形成,并清除LDL氧化过程中产生的与Ox-LDL相关的氧化脂质。